Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor What is Hormone Therapy? Hormonal therapy medicines are whole-body (systemic) treatment for hormone-receptor-
positive breast cancers. Hormone receptors are like ears on breast cells that listen to
signals from hormones. These signals "turn on" growth in cells that have receptors.
Most breast cancers are hormone-receptor-positive.
• About 80% of breast cancers are estrogen-receptor positive.
• About 65% of estrogen-receptor-positive breast cancers are also progesterone-
• About 13% of breast cancers are estrogen-receptor-positive and progesterone-
• About 2% of breast cancers are estrogen-receptor-negative and progesterone-
If a cancer has receptors for either estrogen or progesterone, it's considered hormone-
receptor-positive. There are three different types of hormonal therapy medicines:
SERMs (Selective Estrogen Receptor Modulators):
• Evista (chemical name: raloxifene) • Fareston (chemical name: toremifene)
ERDs (Estrogen Receptor Downregulators):
• Faslodex (chemical name: fulvestrant)
Hormonal therapy medicines can be used to:
• lower the risk of early-stage hormone-receptor-positive breast cancer coming back
Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor
• lower the risk of hormone-receptor-positive breast cancer in women who are at
high risk but haven't been diagnosed with breast cancer
• help shrink or slow the growth of advanced-stage or metastatic hormone-receptor-
Hormone Therapy At a Glance How Your Body Makes Estrogen after Menopause
If you are post-menopausal, most of your estrogen is produced in two steps:
• Your adrenal glands (two small glands that sit on top of your kidneys) make a
hormone called androgen. Androgens are mostly male hormones, but women have
• Then a special protein found in muscle and fat cells throughout your body makes an
enzyme called aromatase, which changes androgen into estrogen.
Hormonal therapy medicines treat hormone-receptor-positive breast cancers in two ways: • by lowering the amount of the hormone estrogen in the body
• by blocking the action of estrogen in the body
Because it targets estrogen, hormonal therapy is also known as anti-estrogen therapy.
Estrogen has many different roles in your body, including keeping your bones strong and
cholesterol low, as well as improving your sense of well-being. Before menopause, most of
the estrogen in a woman's body is made by the ovaries. After menopause, the ovaries stop producing estrogen, but smaller amounts of estrogen are still made in the body; a steroid produced by the adrenal glands is made into estrogen in fat tissue.
After a breast cancer is removed, the cells are tested to see if they have receptors for two
hormones: estrogen and progesterone. If a breast cancer is hormone-receptor-positive, it means that it has these hormone receptors, which act like ears or antennae. When estrogen in the body attaches to the receptors, the breast cancer cells respond to signals from the estrogen that tell the cells to grow and multiply. By reducing the amount of estrogen in the
Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor
body or blocking the effects of estrogen, hormonal therapy medicines can slow the growth of or shrink advanced-stage/metastatic estrogen-receptor-positive breast cancers.
Lowering the amount of estrogen or blocking its effects also can reduce the risk of an early-
stage, estrogen-receptor-positive breast cancer coming back after surgery. Since hormonal
therapy affects the action of estrogen but not progesterone in breast cancer cells, the value of hormonal therapy is less clear if your cancer is progesterone-receptor-positive and estrogen-receptor-negative. In this situation, you should discuss the value of hormonal
In addition to taking a hormonal therapy medicine, premenopausal women diagnosed with hormone-receptor-positive breast cancer or who are at high risk for breast cancer also may
want to consider temporary ovarian shutdown using medication or permanent ovarian
shutdown by surgically removing the ovaries. The ovaries are the main source of estrogen before menopause, so ovarian shutdown or removal stops them from producing estrogen.
Hormonal therapy WON'T work on hormone-receptor-negative breast cancers. Hormone-
receptor-negative breast cancers don't respond to estrogen, so reducing the amount of estrogen in the body doesn't affect hormone-receptor-negative cancers.
Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor Questions to ask your Doctor about Hormone Therapy:
Questions for people who just have been diagnosed with hormone-receptor-positive breast cancer: 1. For my situation, what are the benefits and risks of aromatase inhibitors? 2. For my situation, what are the benefits and risks of tamoxifen?
3. Do you think an aromatase inhibitor or tamoxifen makes more sense for me?
4. Can you compare the side effects of tamoxifen with the side effects of aromatase
5. How many years will I take hormonal therapy?
6. Do I need any tests to determine if I am pre- or postmenopausal?
Questions for people who have taken tamoxifen for 2 to 3 years: 1. Do you think I should switch to an aromatase inhibitor? Why?
2. How much longer would I take tamoxifen if I didn't switch to an aromatase
3. How long would I take an aromatase inhibitor if I did switch?
4. Will I have different side effects if I switch to an aromatase inhibitor?
Florida Breast Health Specialists Hormone Therapy Information and Questions to Ask Your Doctor Questions for people who have finished 5 years of tamoxifen or an aromatase inhibitor: 1. Are there any reasons I should now take a different type of hormonal therapy for an
additional 5 years? (Tamoxifen for women who have finished 5 years of an aromatase inhibitor; an aromatase inhibitor for women who have finished 5 years of tamoxifen.)
2. Are there any reasons why I should keep taking my current hormonal therapy
3. How many years would I take an aromatase inhibitor?
4. How many years would I take tamoxifen?
5. What side effects might I have with an aromatase inhibitor? With tamoxifen?
Don’t forget to see Maggie Monette of the Senior Youth Charles Revson, founder of the successful cosmetic manufacturing firm Group to get your Loblaw’s prepaid/gift cards during coffee Revlon, once said, "In our factory we make lipstick. In our advertising, we sell hope." We could use a little more hope. I think that is Loblaw's, Your Independent, hy people buy lottery tickets
Analyse coût-efficacité des nouveaux neuroleptiques Robert Launois(1) , J. M. Graf von den Schulenburg(2), M. Knapp(3), A. Mégnigbêto(1), J. Reboul-Marty(1) ,M .Toumi 4 (1) Institut de Recherche et d’Evaluation Médicale et Economique - Faculté de Médecine Léonard de Vinci, 74, rue Marcel Cachin, 93017 Bobigny Cedex (France) (2) Universität Hannover (Allemagne) (3) Lond